Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone

Abstract We have developed an immunochemiluminometric assay (ICMA) with two monoclonal antibodies for the N-terminal sequence of human parathyroid hormone (hPTH). One monoclonal antibody (A1–70) was physically adsorbed onto polystyrene beads, the other (B1–70) was labelled with acridinium ester and synthetic hPTH (1–38) was used as standard. This assay has cross-reactions with synthetic hPTH (1–34) and hPTH (1–84) but no cross-reactions with hPTH (4–16), (28–48), (39–84), (44–68), (53–84) and hPTH-rP (1–86). The assay detection limit is 0.4 pmol/l. The normal range is 1.3–12 pmol/l based on 72 normal volunteers. About 91% of study patients ( n = 58) with surgically proven primary hype-rparathyroidism (1°HPT) had PTH values above normal and one of them showed a low normal intact PTH value but elevated PTH values with use of this assay. After immunoabsorption of plasma samples from patients with secondary hyperparathyroidism (2°HPT) on hemodialysis with polystyrene beads containing antibodies against hPTH (39–84), some patients still showed significant amounts of PTH in this new ICMA but not intact PTH. The data reveal that significant amounts of amino-terminal immunoreactive PTH fragments rarely exist in 1°HPT but are present in some patients with 2°HPT. The major advantage of this assay is to measure both amino-terminal PTH fragments and intact PTH with no interference from carboxy-terminal PTH fragments because two anti-N-terminal hormone sequence monoclonal antibodies are used.